Literature DB >> 10337034

C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis.

U Persson1, L Truedsson, K W Westman, M Segelmark.   

Abstract

In ANCA-associated small vessel vasculitis few genetic factors have proven to be of importance for disease susceptibility, an exception being deficiency of alpha1-anti-trypsin, the main inhibitor of proteinase 3 (PR3). Alerted by our finding that myeloperoxidase has affinity for C3, and the finding of an increased frequency of the C3F allele in systemic vasculitis in a British cohort, we examined polymorphism of C3 and C4 in patients with ANCA+ small vessel vasculitis. After identification of all patients at our department with a positive ANCA test during the period 1991-95 and a diagnosis of small vessel vasculitis, blood samples were collected after informed consent. The 67 included patients were grouped according to ANCA serology and disease phenotype using the Chapel Hill nomenclature. The gene frequency of C3F was found to be increased (0. 32) compared with controls (0.20; P < 0.05) in the PR3-ANCA+ subgroup. The frequency of C4A3 was increased in the group as a whole, but no increase of C4 null alleles was seen. The findings imply a role for the complement system in the pathogenesis of ANCA-associated small vessel vasculitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337034      PMCID: PMC1905284          DOI: 10.1046/j.1365-2249.1999.00889.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Functional consequences of the genetic polymorphism of the third component of complement.

Authors:  T R Welch; L Beischel; A Kleesattel
Journal:  J Pediatr       Date:  1990-05       Impact factor: 4.406

2.  Phenotyping of human complement component C4, a class-III HLA antigen.

Authors:  E Sim; S J Cross
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

3.  Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement.

Authors:  K W Westman; P G Bygren; H Olsson; J Ranstam; J Wieslander
Journal:  J Am Soc Nephrol       Date:  1998-05       Impact factor: 10.121

4.  Difference in the biological properties of the two forms of the fourth component of human complement (C4).

Authors:  J A Schifferli; G Steiger; J P Paccaud; A G Sjöholm; G Hauptmann
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

5.  Studies on the C3 polymorphism. Relationship between phenotype and quantitative immunochemical measurements.

Authors:  R Brönnestam
Journal:  Hum Hered       Date:  1973       Impact factor: 0.444

6.  Genetic control of survival in epidemics.

Authors:  R R de Vries; P Meera Khan; L F Bernini; E van Loghem; J J van Rood
Journal:  J Immunogenet       Date:  1979-08

7.  Genetic polymorphism of the third component of human complement (C'3).

Authors:  C A Alper; R P Propp
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

8.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

10.  Molecular basis of polymorphisms of human complement component C3.

Authors:  M Botto; K Y Fong; A K So; C Koch; M J Walport
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Genetics of ANCA-associated Vasculitides.

Authors:  Manuel F Ugarte-Gil; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2014-07       Impact factor: 4.592

Review 2.  The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis.

Authors:  Lisa C Willcocks; Paul A Lyons; Andrew J Rees; Kenneth G C Smith
Journal:  Arthritis Res Ther       Date:  2010-02-15       Impact factor: 5.156

Review 3.  Renal involvement in Wegener's granulomatosis.

Authors:  Y Renaudineau; Y Le Meur
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 4.  Advances in the genomics of ANCA-associated vasculitis-a view from East Asia.

Authors:  Aya Kawasaki; Naoyuki Tsuchiya
Journal:  Genes Immun       Date:  2021-03-08       Impact factor: 2.676

5.  Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia.

Authors:  Nadia Leban; Karim Jraba; Abdelkader Chalghoum; Selma Hassine; Donia Elhayek; Sabri Denden; Ramzi Lakhdhar; Faouzi Maatoug; Habib Gamra; Hammadi Braham; Jemni Ben Chibani; Amel Haj Khelil
Journal:  Diagn Pathol       Date:  2013-06-13       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.